Clinical Trials in Ohio

Showing 5261-5280 of 15,929 trials

A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)

NCT05717920

A Phase 2, multicenter, adaptive 2-part clinical trial designed to evaluate the safety and efficacy of ADX-629 alone and in combination with standard-of-care in adults with atopic dermatitis.

Atopic Dermatitis

Aldeyra Therapeutics, Inc.8 participantsStarted Feb 2023

Bexley, Ohio, United States

COMPLETEDNA32 miles

Preemie Hypothermia for Neonatal Encephalopathy

NCT01793129

This study is a randomized, controlled trial to assess safety and effectiveness of whole body hypothermia for 72 hours in preterm infants 33-35 weeks gestational age (GA) who present at \<6 hours postnatal age with moderate to severe neonatal encephalopathy (NE). The study will enroll infants with signs of NE at 18 NICHD Neonatal Research Network sites, and randomly assign them to either receive hypothermia or participate in a non-cooled control group.

Infant, NewbornHypoxia, BrainHypoxia-Ischemia, Brain+3 more

NICHD Neonatal Research Network168 participantsStarted May 2015

Birmingham, Alabama, United States • Palo Alto, California, United States • Atlanta, Georgia, United States +15 more locations

A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)

Preemie Hypothermia for Neonatal Encephalopathy

Find Trials by Condition in Ohio

A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Entyvio (Vedolizumab) Long Term Safety Study

A Study of ASP1951 in Subjects With Advanced Solid Tumors

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug

A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma

Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Vaginal Photobiomodulation for Chronic Pelvic Pain

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.